International Scientific Publications
© 2007-2026 Science Events Ltd
Terms of Use  ·  Privacy Policy
Language English French Polish Romanian Bulgarian
Conference room
Materials, Methods & Technologies 2026, 28th International Conference
13-16 August, Burgas, Bulgaria
Call for Papers

Materials, Methods & Technologies, Volume 3, 2009

BIOMEDICAL POTENTIAL FULLERENES (C60)
Radu-Claudiu Fierascu, Rodica-Mariana Ion, Irina Dumitriu
Pages: 394-406
Published: 1 Jan 2009
Views: 186
Downloads: 15
Abstract: The most abundant form of fullerenes family is buckminsterfullerene (C60) with 60 carbon atoms arranged in a spherical structure. The unique physical and chemical features of C60, have recently incited a considerable hope of its possible use in various fields of biomedicine. Many fullerene-based compounds with different biological targets have been synthesized, displaying a range of biological activities potentially useful in anticancer or antimicrobial therapy, cytoprotection, enzyme inhibition, controlled drug delivery and contrast- or radioactivity-based diagnostic imaging. The purpose of our study is the in vitro analysis of a novel compound – tetraphenyl-porhyrin-polyvinylpyrolidone-C60 fullerene (TPP-PVP-C60) – upon K562 leukemia cell line, in order to determine the toxicological outline of this modified fullerene and to evaluate its candidature for a potential photosensitizer agent. The triple complex - PVP+C60+tetraphenylporphyrin was synthesized in this paper.
Keywords: copper artefacts, archaeometallurgy
Cite this article: Radu-Claudiu Fierascu, Rodica-Mariana Ion, Irina Dumitriu. BIOMEDICAL POTENTIAL FULLERENES (C60). Journal of International Scientific Publications: Materials, Methods & Technologies 3, 394-406 (2009). https://www.scientific-publications.net/en/article/1003496/
Back to the contents of the volume

Submit Feedback

We value your input! Use this form to report any concerns or provide feedback on our published articles. All submissions will be kept confidential.

By using this site you agree to our Privacy Policy and Terms of Use. We use cookies, including for analytics, personalisation, and ads.